| Product NDC: | 68180-334 |
| Proprietary Name: | Ziprasidone Hydrochloride |
| Non Proprietary Name: | Ziprasidone Hydrochloride |
| Active Ingredient(s): | 80 mg/1 & nbsp; Ziprasidone Hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 68180-334 |
| Labeler Name: | LUPIN PHARMACEUTICALS INC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA077560 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120302 |
| Package NDC: | 68180-334-07 |
| Package Description: | 60 CAPSULE in 1 BOTTLE (68180-334-07) |
| NDC Code | 68180-334-07 |
| Proprietary Name | Ziprasidone Hydrochloride |
| Package Description | 60 CAPSULE in 1 BOTTLE (68180-334-07) |
| Product NDC | 68180-334 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Ziprasidone Hydrochloride |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20120302 |
| Marketing Category Name | ANDA |
| Labeler Name | LUPIN PHARMACEUTICALS INC |
| Substance Name | ZIPRASIDONE HYDROCHLORIDE |
| Strength Number | 80 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Atypical Antipsychotic [EPC],Atypical Antipsychotic [EPC] |